- Home
- QNCX vs ZTG Comparison
QNCX vs ZTG Comparison
Compare QNCX & ZTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$33.75
N/A
Current Price
$0.90
Company Overview
Basic Information| Metric | QNCX | ZTG |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | Macau |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5M | 20.4M |
| IPO Year | 2019 | 2024 |
Fundamental Metrics
Financial Performance| Metric | QNCX | ZTG |
|---|---|---|
| Price | $33.75 | $0.90 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.5K | ★ 1.4M |
| Earning Date | 04-10-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $0.75 |
| 52 Week High | $35.41 | $12.25 |
Technical Indicators
Market Signals| Indicator | QNCX | ZTG |
|---|---|---|
| Relative Strength Index (RSI) | 61.57 | 33.77 |
| Support Level | $0.82 | N/A |
| Resistance Level | $35.41 | $12.25 |
| Average True Range (ATR) | 2.46 | 1.43 |
| MACD | -0.79 | -0.69 |
| Stochastic Oscillator | 34.79 | 1.99 |
Price Performance
Historical Comparison QNCX
ZTG
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.